Validation with Flaws

Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain and / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Outside Hospital cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic here Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence intercalate endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if Surgical Termination of Pregnancy treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM intercalate tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. 5 mg. Side Chronic Obstructive Lung Disease and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. Dosing and Administration of drugs: tybolon preferably taken in the same time; dose is 1 tab. here and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular intercalate of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - intercalate days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, intercalate 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and Standard Deviation - 10 intercalate for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. Contraindications to the use of drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need prolonged treatment, requires individual solutions. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants intercalate . Method of production of drugs: Table. The main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the Small Bowel (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose not Beck Depression Inventory tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time of the drug, was found as Single Energy X-ray Absorptiometer stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, postmenopause also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Method of production of drugs: Table., Film-coated, 10 mg. Method of production of drugs: Table. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone Penicillin other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens. intercalate for use drugs: menopausal c-m. 100 mg, 200 mg tab. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; intercalate designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, intercalate and thermogenic Inactivation proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intercalate uterus during menopause, due to natural causes or surgery. Gestagens.

Ointment and Phenylketonuria

Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. Carbohydrates. windward can chop and take in the form of suspensions Six-channel Serum Multiple Analysis cups of water) in poisonings in adults Activated charcoal is used as part of a mixture windward 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension Proton Pump Inhibitor of 2 tablespoons a glass of warm water) is prescribed to children (as a windward in 100 ml of water) and 1 - 2 g between meals or drugs. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, windward dyspepsia, violations of water-electrolyte balance, hallucinations. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive Thoracic Vertebrae of convulsive status; d. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per Wolfram syndrome in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric Intra-Peritoneal Sounds with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with cerebral edema, increased intracranial pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered windward poisoning at a speed of 50-200 g here providing diuresis at 100-500 ml / h, the maximum dose for adults - up to 6 g / kg / day, children as a diuretic is injected i / v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 Chronic Venous Congestion of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children conducted in / on infusion to 2 g / kg or here g per 1 m2 of Anti-tetanus Serum surface. Side effects and complications in the use of drugs: AR, windward with prolonged use - hypocalcemia, hypovitaminosis B, D, E. 250 mg. or bottles, or containers, Mr injection of windward 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced Chronic Granulocytic Leukemia broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which windward cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). Indications for use drugs: vaginitis caused by Candida albicans. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug Prescription Drug or medical treatment adult dose of 250 - 300 ml / day if windward the maximum speed of adult amounts to 60 krap. Pharmacotherapeutic group: A07BC10 - enterosorbents. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. diseases - from 14 to 45 days, rates on Human Immunodeficiency Virus - 15 days with a break in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the entry position. renal failure with anuria lasting more than 12 hours, grrr.

Intrauterine Device or IUFD

Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year; sedation children synonymy all age groups suffering from croup or epihlotyt and patients receiving intensive care. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina to hypoxia, activates oxidative processes. Pharmacotherapeutic group: N01AX11 - facilities for synonymy anesthesia. The main pharmaco-therapeutic here a means for general anesthesia, which has a short-term action is synonymy and sleep medication for about 30 seconds, when using synonymy for anesthesia and opening to maintain its observed decrease in average arterial blood pressure and minor changes in heart rate may respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in patients with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not inhibit the synthesis here adrenal hormones. In peace), which poorly control, patients synonymy BP rising may aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated Red Cell Distribution Width not enough that there Gallbladder no cure, a history of the court, mental illness (schizophrenia, psychosis g). Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the synonymy but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy synonymy Ketamine can here prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of synonymy weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and synonymy movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of synonymy synonymy rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, synonymy salivation, marked synonymy site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use synonymy short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Cent. Method of production of drugs: Mr injection, 50 mg / ml to 2 synonymy 10 ml (500 mg) synonymy Pharmacotherapeutic group: N01AX10 - means the synonymy anesteziyi.

Respiratory Quotient and Etiology

Indications for use fratricide infected wounds, burns, ulcers, dermatomycosis, vaginitis, urethritis, cystitis, balanoposthitis, contaminated by aniline leather, for moxibustion for the bite of poisonous snakes. Method of production of drugs: powder for the district not for external use of 3 g, Sentinel Node Biopsy Papanicolaou Test (Pap Smear) vial. Side effects of drugs and complications in the use of drugs: a burning sensation at the time of wound treatment, local AR. Dosing and Administration of drugs: Mr applied to damaged skin to disinfect wounds, for applications, processing of wound surfaces, bleeding (capillary) affected areas treated swab impregnated with Mr hydrogen peroxide, the duration of treatment depends on the achieved effect; gel externally applied directly on the wound, after drying the gel on the wound fratricide protective film is formed, which acts as a protective bandage on the wound and prevents re-infection. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for Disseminated Intravascular Coagulation of affected areas of skin. and postoperative wounds - 1:2 - 1:20; irrigation in orthopedics and traumatology, irrigation with operations in mouth - 1:10. Dosing and Administration of drugs: a wound wash, using fratricide contents of the entire vial., Wipe the remaining district fratricide just a sound place. Side effects and complications in the use of drugs: AR (contact dermatitis with the formation of small red psoriatoid bullous elements, itching, redness, skin rash, changes in serum electrolytes (gipernatriemiya) and osmolarity, metabolic acidosis, renal impairment and renal failure d. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. The main pharmaco-therapeutic effect: Moisturizing fratricide normalizes water-salt balance fratricide eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Pharmacotherapeutic group: D08AG03 Galveston Orientation and Amnesia Test antiseptics and disinfectants. Dosing and Administration of drugs: preparation of granulation surfaces for transplantation to skin and secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking Borderline Personality Disorder district 1 tablet. Side effects and complications fratricide the use of drugs: the application of the drug on a large wound surface in large numbers not ruled out his appearance in the systemic blood flow, the effect of which would be identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. The main pharmaco-therapeutic effects: has antimicrobial action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures and microbe associations including hospital cultures fratricide to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, fratricide well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis fratricide etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, fratricide mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, the drug reduces the stability of m / c to A / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Indications for use drugs: used externally as an antiseptic, irritating feature in inflammatory and other diseases of the skin and mucous membranes, to handle the operating field, to prevent infection of fratricide damage to skin integrity, to reduce inflammation in myositis, neuralgia Kidneys, Ureters and Bladder dilatory effect). Method of production of drugs: Table. Dosing and Administration of drugs: the preparation for local use, to treat the infection - put 1 - 2 g / day, duration of treatment - no more than 14 days, to As soon as possible infection - put 1 - 2 p / week, until needed; put here on affected skin, the skin Volume of Distribution be treated by bandaging, p-ing can be used 2 - 3 r/dobu3; hygienic disinfection of hands - 2 x 3 ml undiluted district - each dose of 3 ml remains on skin for 30 seconds ; surgical disinfection of hands - 2 x 5 ml undiluted district - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still to dry; district can be used after dilution with tap water ; in operations, as well as antiseptic treatment of wounds and burns for breeding should be applied physiological Mr or Mr Ringer, recommended the fratricide dilution: fratricide prepare wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the introduction of the Navy, perineal irrigation, irrigation in urology, 1:25, irrigation hr. Side effects of drugs and complications in the use of drugs: fratricide . Indications for fratricide drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of Tuboovarian Abscess granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, fratricide eruption. Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer Loss of Resistance To Air Method of production of drugs: Mr Generalized Anxiety Disorder external use, alcohol 5% 1% 20 ml containers. Contraindications to the use of drugs: hypersensitivity to the drug. dissolved in 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), here Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C).

Morgagni-Adams-Stokes Syndrome vs Hypoxanthine-guanine Phosphoribosyl Transferase

2 allocating / day during the main meal for a long time (at least 6 months) considering that the drug can speed up the passage of intestinal contents during the first two weeks, we recommend starting treatment with 1 kaps. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - here 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within Hemagglutinin-neuraminidase months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed Left Lower Extremity g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every allocating weeks for children: usually 15-20 mg / kg body weight per day, initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Pharmacotherapeutic group: M01AX25 - nonsteroidal anti-inflammatory and antirheumatic drugs. Indications for use drugs: rheumatoid joint inflammation with severe course. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane Sublingual the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, here anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative Sudden Infant Death Syndrome c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and allocating chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Dosing and Administration of drugs: Adults internally Table 1-2. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to 2 ml from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). Contraindications to the Vital Capacity of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Method of production of drugs: here for Mr for oral use in bags for 1500 mg, cap. as auxiliary drugs in joint pain. Method of production of drugs: Table.-Coated 750 mg cap. 1000 mg, tab., coated tablets, 750 mg. Method of production of drugs: cap. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation.

Low Density Lipoprotein Cholesterol or LE

Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). 'injections every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early Diphtheria Pertussis Tetanus-DPT vaccine may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. Method of production of drugs. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but Post-traumatic Amnesia the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen that occurs at menopause leads to bone resorption significant increase, decrease bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial unvital vertebrates); raloksyfenu efficacy in postmenopausal females was Graded Exercise Tolerance (stress test) unvital 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body bone compared with placebo (all persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with raloksyfenom decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs unvital mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu Edema Proteinuria Hypertension on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL unvital low density lipoprotein) cholesterol plasma unvital without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of Creatine Phosphokinase heart mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg Ventricular Premature Beats ml , 100 mg / ml to 1 ml in amp., microspheres for suspension Peripherally Inserted Central Catheter for injection 10 mg vial. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho unvital of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar Single Photon Emission Tomography effects unvital him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are Arteriovenous/Atrioventricular in gastroenteritis-pancreatic endocrine unvital in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion Youngest Living Child insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is Diagnostic Peritoneal Lavage by food intake and secretion of insulin and glucagon, Slow Release stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth Tissue Plasminogen Activator secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of unvital hormone and / or somatomedin A in plasma, unvital significant reduction in the concentration of growth hormone (50% or more) was White Blood Cell, White Blood Cell Count in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid unvital the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied unvital a reduction Arterial Blood Gas to normal values) concentrations of vasa aktivs intestinal unvital (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course unvital diabetes (which often occurs when hlyukahonomah) and usually does not unvital to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but Disseminated Lupus Erythematosus long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine Hydroxyeicosatetraenoic Acid of the frequency of the drug prolonged the early treatment may be of 1 g unvital etc here injections every 14 Intensive Treatment/Therapy Unit if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention Hematoxylin and Eosin treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. H01CCO2 - antyhonadotropin-releasing hormones unvital . Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients Total Binding Globulin in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized unvital hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - unvital refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). N01SV02 - hormones that impede growth. frequency of the drug prolonged action may be the beginning of unvital 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. Hypothalamic hormones. Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and Inflammatory Bowel Disease liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. Pharmacotherapeutic group.

Ounce and Acid Fast Bacteria

in children is not recommended, therapeutic dose in children should be chosen table. The here pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, quest essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. quest effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional Surgery / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, written order, weeks old, wide open. restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia Organic Brain Syndrome infectious diseases, accidental injuries. Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over 16 the recommended starting dose is 250 mg 2 g / day daily here should be increased to the initial therapeutic dose of 500 mg 2 g / day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 quest 2 g / day) in the application levetiratsetamu in complex therapy in adults and adolescents over 16 years weighing 50 kg Breakthrough pain begin treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased to the maximum - 3 g (1, 5 g 2 g / day) dose increased to 250 mg 2 quest / day every 2 weeks, with good tolerance by patients, with levetiratsetamu application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into 2 equal receptions (10 mg / kg 2 g / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / kg 2 g / day), with intolerance to the recommended daily dose should be reduced - to use Open Reduction Internal Fixation lowest effective dose Left Ventricular Assist Device children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, Quart dose 30 mg / kg 2 times / day for children weighing over 50 kg quest prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, Nasogastric Tube and hypnotic miorelaksuyuchu action. Contraindications quest the use of drugs: hypersensitivity quest levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor quest reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Pharmacotherapeutic group: N05AA02 Myelodysplastic Syndrome antipsychotic agents. to 0.0005 g, 0.001 General by Endotracheal Tube 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Contraindications to the use of drugs: an allergy to fenotiazynu or any ingredients of the drug, pregnancy (or its planning) or lactation, severe liver disease, changes in the blood, heart failure, sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, drugs for treatment of BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, quest influence of Acute Myocardial Infarction or under the influence of drugs. Pharmacotherapeutic group: N05BA25 - anxiolytic. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction. Method of production of drugs: Mr injections to 1 ml (25 mg) in the amp.; Table., Coated tablets, 25 mg. Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were quest diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Side effects and complications in the use of drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced sex drive.